ProImmune Limited Launches ProArray Ultra: A New Protein and Peptide Microarray Platform with True Analytical Grade Performance  
6/15/2011 7:08:05 AM

OXFORD, England--(BUSINESS WIRE)--ProImmune Ltd., a leader in services for understanding immune responses, announced today that it has launched ProArray Ultra™, a uniquely powerful protein and peptide array platform, which is more sensitive than optimized ECL ELISA. The new platform allows analysis of more than 30,000 peptides or proteins at once, and typically requires only 1ul of analyte sample. With its sensitivity and flexibility, ProArray Ultra overcomes the traditional trade-off between optimized 96-well plate-based assays, which are reliable and have good performance characteristics but lack the required throughput, and high throughput array technologies, which are typically only semi-quantitative.